241 results
Page 10 of 13
8-K
EX-99.1
jfa8jn0l0j yfhktmp
15 Mar 11
BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
12:00am
8-K
eyxokv60sb5rh
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
EX-99.1
5m54dxy92sjdxc6wqgr
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
sl97a
28 Jan 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
xd1e6sd2q9k1
10 Jan 11
BioTime’s CEO Michael West to Present Preclinical Data on OTX-CP03 and OTX-CP07 for the Treatment of Osteoarthritis at STEM 2011 in Gurgaon, India
12:00am
8-K
EX-99.1
meir6y k9hf11r
3 Jan 11
BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
12:00am
8-K
kqr9tdc
3 Jan 11
BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
12:00am
8-K/A
EX-99.2
r1dw1his
16 Jul 10
Completion of Acquisition or Disposition of Assets
12:00am
8-K
qdgcbbfr02o
3 May 10
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-99.1
e0kyh781q t5
3 May 10
BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition
12:00am